This could lead to improved management of comorbidities and, ultimately, enhance the quality of life for individuals with obesity, she suggested
Important considerations: GLP-1 receptor agonists should not replace established antihypertensive medications and should only be initiated for their licensed indications according to NICE guidance
The Food and Drug Administration (FDA) keeps a database of adverse effects to track potential risks of medications
But research has linked GLP-1 agonists to serious digestive problems such as gastroparesis, pancreatitis and intestinal obstructions
The Role of Semaglutide in Weight Loss Semaglutides mechanism of actionmimicking natural GLP-1 to enhance insulin release, slow gastric emptying, and promote satietynaturally lends itself to weight loss
I used to white-knuckle my injections, dreading them all week